ViroGates AS (OCSE:VIRO) Total Liabilities: kr9.98 Mil (As of Mar. 2026)


OCSE:VIRO ViroGates AS OCSE:VIRO
46 GF Score
Price kr10.20
GF Value kr6.76
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is ViroGates AS Total Liabilities?

ViroGates AS OCSE:VIRO 46 Total Liabilities is kr9.98 Mil as of Mar. 2026. GuruFocus rates OCSE:VIRO with a GF Score™ of 46/100 and a GF Value™ of kr6.76 (Significantly Overvalued). The stock has 2 warning signs investors should review.

ViroGates AS's Total Liabilities for the quarter that ended in Mar. 2026 was kr9.98 Mil.

ViroGates AS's quarterly Total Liabilities declined from Sep. 2025 (kr11.38 Mil) to Dec. 2025 (kr11.19 Mil) and declined from Dec. 2025 (kr11.19 Mil) to Mar. 2026 (kr9.98 Mil).

ViroGates AS's annual Total Liabilities declined from Dec. 2023 (kr7.55 Mil) to Dec. 2024 (kr6.87 Mil) but then increased from Dec. 2024 (kr6.87 Mil) to Dec. 2025 (kr11.19 Mil).

ViroGates AS Total Liabilities Historical Data

* Premium members only.

The historical data trend for ViroGates AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViroGates AS Total Liabilities Chart

ViroGates AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.80 1.45 7.55 6.87 11.19

ViroGates AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.01 13.22 11.38 11.19 9.98
OCSE:VIRO
46GF Score
ViroGates AS OCSE:VIRO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ViroGates AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ViroGates AS's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.856+(3.33+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=11.19

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=30.589-19.403
=11.19

ViroGates AS's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.962+(3.017+0.0010000000000008
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.98

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=26.771-16.791
=9.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of kr9.98 Mil mean?
ViroGates AS (OCSE:VIRO) has a Total Liabilities of kr9.98 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ViroGates AS and its competitors.
Is ViroGates AS's Total Liabilities too high?
ViroGates AS's current Total Liabilities is kr9.98 Mil. Overall, ViroGates AS has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ViroGates AS's Total Liabilities compare to ABT and SYK?
ViroGates AS's Total Liabilities of kr9.98 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ViroGates AS and its competitors. ViroGates AS's current Total Liabilities is kr9.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViroGates AS stock overvalued right now?
Based on GuruFocus' analysis, ViroGates AS (OCSE:VIRO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr6.76, compared to a current price of kr10.20 — trading 50.9% above its estimated fair value. The current Total Liabilities is kr9.98 Mil. ViroGates AS's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For ViroGates AS (OCSE:VIRO), the current Total Liabilities is kr9.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ViroGates AS (OCSE:VIRO) Overvalued in 2026?

Based on GuruFocus' analysis, ViroGates AS stock appears to be overvalued. The current stock price of kr10.20 is trading 50.9% above its estimated GF Value™ of kr6.76. GuruFocus considers ViroGates AS to be Significantly Overvalued.

Key valuation signals for OCSE:VIRO:

  • Total Liabilities: kr9.98 Mil
  • GF Value™: kr6.76 vs. price of kr10.20 (50.9% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the OCSE:VIRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ViroGates AS Business Description

Address Banevaenget 13, Birkerod, DNK, 3460
ViroGates AS is an international medical technology company that develops and markets blood tests to measure chronic inflammation at health clinics and hospitals. The company markets its blood test products under the suPARnostic brand. Its product portfolio comprises suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic Auto Flex ELISA kit. These products are mainly used to measure the suPAR (soluble urokinase Plasminogen Activator Receptor) protein in the bloodstream.
46GF Score

Get the complete analysis for OCSE:VIRO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.20
Price
kr6.76
GF Value